FVIIa:TF induces cell survival via G12/G13-dependent Jak/STAT activation and BclXL production

Circ Res. 2004 Apr 30;94(8):1032-40. doi: 10.1161/01.RES.0000125625.18597.AD. Epub 2004 Mar 11.

Abstract

Tissue factor (TF), apart from activating the extrinsic pathway of the blood coagulation, is a principal regulator of embryonic and oncogenic angiogenesis, inflammation, leukocyte reverse transmigration, and tumor progression. It has become clear that these events are mediated by intracellular signal transduction elicited by TF/factor VIIa (FVIIa) interaction, but the details of this signaling remain largely obscure. In this study, we show that FVIIa/TF-interaction produces STAT5 phosphorylation, STAT5 nuclear translocation and transactivation of a STAT5 reporter construct. FVIIa-dependent STAT5 activation was dependent on FVIIa proteolytic activity but not on generation of the downstream coagulation factors Xa and thrombin, nor on the TF cytoplasmic domain. FVIIa-induced STAT5 phosphorylation was dependent on functional G12/G13 class G proteins and Jak2 activity, but not Jak1 or Tyk2. Finally, we show that FVIIa leads to cell survival through a Jak2/STAT5-dependent production of the antiapoptotic STAT5 target Bcl(XL) as well as Jak2-dependent activation of the antiapoptotic protein PKB. In conclusion, our results show that FVIIa induces cell survival through STAT5-dependent Bcl(XL) production and Jak2-dependent activation of PKB. Finally, we demonstrated for the first time that TF/FVIIa-signal transduction is dependent on G12/G13 class G proteins.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Active Transport, Cell Nucleus
  • Animals
  • Cell Line / drug effects
  • Cell Survival / drug effects
  • Cricetinae
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / physiology
  • Enzyme Inhibitors / pharmacology
  • Factor VII / antagonists & inhibitors
  • Factor VII / genetics
  • Factor VII / pharmacology*
  • Factor VIIa / physiology
  • GTP-Binding Protein alpha Subunits, G12-G13 / physiology
  • Gene Expression Regulation / drug effects
  • Hirudins / pharmacology
  • Janus Kinase 2
  • Mesocricetus
  • Milk Proteins*
  • Phosphorylation / drug effects
  • Protein Processing, Post-Translational / drug effects
  • Protein-Tyrosine Kinases / genetics
  • Protein-Tyrosine Kinases / physiology
  • Proto-Oncogene Proteins c-bcl-2 / biosynthesis
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Proto-Oncogene Proteins*
  • Recombinant Fusion Proteins / physiology
  • Recombinant Proteins / antagonists & inhibitors
  • Recombinant Proteins / genetics
  • Recombinant Proteins / pharmacology*
  • STAT5 Transcription Factor
  • Signal Transduction / drug effects*
  • Thrombin / antagonists & inhibitors
  • Thrombin / biosynthesis
  • Thromboplastin / chemistry
  • Thromboplastin / genetics
  • Thromboplastin / pharmacology*
  • Thromboplastin / physiology
  • Trans-Activators / genetics
  • Trans-Activators / physiology
  • Transcriptional Activation
  • Transfection
  • Tyrphostins / pharmacology
  • bcl-X Protein

Substances

  • DNA-Binding Proteins
  • Enzyme Inhibitors
  • Hirudins
  • Milk Proteins
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • Recombinant Fusion Proteins
  • Recombinant Proteins
  • STAT5 Transcription Factor
  • Trans-Activators
  • Tyrphostins
  • alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide
  • bcl-X Protein
  • Factor VII
  • Thromboplastin
  • recombinant FVIIa
  • Protein-Tyrosine Kinases
  • Janus Kinase 2
  • Factor VIIa
  • Thrombin
  • GTP-Binding Protein alpha Subunits, G12-G13